| J9271 | Injection, pembrolizumab, 1 mg | 26,000 | $40 | $1.1M |
| J0897 | Injection, denosumab, 1 mg | 18,180 | $20 | $309.1K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 5,250 | $30 | $168K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 67,370 | $1 | $134.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,760 | $70 | $119.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 720 | $90 | $67.9K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,100 | $20 | $49.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 390 | $100 | $39.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 1,560 | $20 | $35.8K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 630 | $50 | $31.6K |